See It All. Understand It All.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
Social Media
Republican Party
US Politics
Natural Disasters
Democratic Party
Donald Trump
Money
Senate
LGBTQ+
Drones
Education
Published • loading... • Updated

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis

Summary by Hastings Tribune
SAN DIEGO--(BUSINESS WIRE)--May 28, 2025-

2 Articles

All
Left
Center
1
Right
Hastings TribuneHastings Tribune
Center

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis

SAN DIEGO--(BUSINESS WIRE)--May 28, 2025-

Read Full Article
pharmaceutical-technology.compharmaceutical-technology.com

Regeneron to deploy Telesis Bio’s platform at R&D facilities

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D facilities.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Wednesday, May 28, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

DNA

DNA

San Diego

San Diego

News
For You
SearchBlindspotLocal